Medicare was Encompass Health’s largest revenue line in fiscal 2025, bringing in $3.89B of $5.94B (65%).
| Counterparty Name | FY 2020 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Medicare | $2.84B | $3.13B | $3.50B | $3.89B | |
| Medicare Advantage | $654.60M | $776.10M | $903.70M | $974.40M | |
| Managed Care | $505.20M | $531.40M | $579.20M | $634.00M | |
| Medicaid | $183.30M | $190.70M | $179.40M | $184.20M | |
| Other Income | $81.60M | $94.40M | $130.20M | $169.20M | |
| Other Third-Party Payors | $39.50M | $41.80M | $41.70M | $39.70M | |
| Workers’ Compensation | $24.70M | $25.80M | $27.80M | $29.60M | |
| Patients | $16.60M | $14.90M | $15.90M | $17.20M | |
| Total | $4.35B | $4.80B | $5.37B | $5.94B |
Encompass Health brought in $5.94B from its eight revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 10.5% from $5.37B in fiscal 2024. Medicare was the largest at $3.89B (65.5%), ahead of Medicare Advantage at $974.40M (16.4%) and Managed Care at $634.00M (10.7%). The other five revenue lines brought in $439.90M combined.
Compared with fiscal 2024, Other Income grew fastest, up 30.0% to $169.20M. Every revenue line above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $4.35B to $5.94B, a compound annual growth rate of 10.9%. Medicare's share held steady at about 65.5%.
Inpatient was Encompass Health’s largest product and service line in fiscal 2025, bringing in $5.76B of $5.94B (97%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Inpatient | $4.25B | $4.69B | $5.23B | $5.76B |
| Other | — | $107.40M | $142.70M | $178.90M |
| Outpatient & Other | $97.00M | — | — | — |
| Total | $4.35B | $4.80B | $5.37B | $5.94B |
Encompass Health brought in $5.94B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 10.5% from $5.37B in fiscal 2024. Inpatient was the largest at $5.76B (97.0%), ahead of Other at $178.90M (3.0%).
Compared with fiscal 2024, Other grew 25.4% to $178.90M and Inpatient grew 10.1% to $5.76B.
Encompass Health began breaking out Other in fiscal 2023, when it brought in $107.40M. Encompass Health stopped reporting Outpatient & Other as a separate line after fiscal 2022, when it brought in $97.00M.
Guarantor Subsidiaries was Encompass Health’s largest revenue line in fiscal 2015, bringing in $1.89B of $3.12B (61%).
| Legal Entity | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 |
|---|---|---|---|---|---|
| Guarantor Subsidiaries | $1.56B | $1.62B | $1.66B | $1.89B | |
| Non-Guarantor Subsidiaries | $649.30M | $709.80M | $787.00M | $1.31B | |
| Parent Company | $9.00M | $12.20M | — | $19.40M | |
| Parent | — | — | — | — | |
| Consolidation, Eliminations | -$59.20M | -$71.20M | — | -$103.50M | |
| Total | $2.16B | $2.27B | $2.45B | $3.12B |
Encompass Health brought in $3.12B from its four revenue lines in fiscal 2015, the year ended December 31, 2015. Encompass Health regrouped these revenue lines after fiscal 2014, so the total does not compare directly with that year's $2.45B. Guarantor Subsidiaries was the largest at $1.89B (60.7%), ahead of Non-Guarantor Subsidiaries at $1.31B (42.0%) and Parent Company at $19.40M (0.6%).
Compared with fiscal 2014, Non-Guarantor Subsidiaries grew 66.1% to $1.31B and Guarantor Subsidiaries grew 13.9% to $1.89B. From fiscal 2012 to 2015, combined revenue from these revenue lines grew from $2.16B to $3.12B, a compound annual growth rate of 13.0%. Guarantor Subsidiaries' share of the total fell from 72.3% to 60.7%.
The total is net of Consolidation, Eliminations, which took $103.50M off revenue in fiscal 2015.
Encompass Health (EHC) reports its revenue by counterparty name, by product and service and by legal entity. In fiscal 2025, Medicare was its largest revenue line, bringing in $3.89B (65.5% of the total), followed by Medicare Advantage at $974.40M (16.4%).
Medicare was Encompass Health's largest revenue line in fiscal 2025, bringing in $3.89B, or 65.5% of the $5.94B total across its eight revenue lines.
Inpatient was Encompass Health's largest product and service line in fiscal 2025, bringing in $5.76B, or 97.0% of the $5.94B total across its two product and service lines.
Among Encompass Health's revenue lines that make up at least 2% of revenue, Other Income grew fastest in fiscal 2025, up 30.0% from $130.20M to $169.20M.
Every figure comes from Encompass Health's annual financial filings, as reported. Each line keeps the name Encompass Health gives it, and years follow its fiscal calendar.
Encompass Health's revenue by counterparty name goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.